We’ve recently refined our corporate brand identity and launched three new Curia sub-brands to highlight what we stand for and what #differentiates us as a CDMO partner. Watch the video to learn more about how we empower our customers to deliver impactful results across different #modalities and therapeutic services.
#SmallMolecules: Providing strategic solutions for drug substance discovery, development, and manufacturing, Curia Small Molecules leads the way in high-profile therapeutic areas.
#GenericAPIs: Setting the global standard for the timely delivery of both generic and commercial APIs, Curia Generic APIs ensures unmatched quality and safety.
#Biologics: With a comprehensive portfolio from drug discovery to GMP manufacturing, Curia Biologics is a leader in innovation, leveraging proven expertise in biologics.